Diagnostic efficacy of activated partial thromboplastin time waveform and procalcitonin analysis in pediatric meningococcal sepsis

被引:4
作者
Paize, Fauzia [1 ,2 ]
Carrol, Enitan [1 ,2 ]
Downey, Colin [5 ]
Parry, Christopher M. [2 ]
Green, Gerwyn [6 ]
Diggle, Peter [6 ]
Newland, Paul [4 ]
Riordan, F. A. I. [3 ]
Thomson, Alistair [1 ]
Hart, C. A. [2 ]
Toh, Cheng-Hock [2 ,5 ,7 ]
机构
[1] Univ Liverpool, Inst Child Hlth, Alder Hey Childrens Natl Hlth Serv NHS Fdn Trust, Liverpool L69 3BX, Merseyside, England
[2] Univ Liverpool, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England
[3] Alder Hey Childrens NHS Fdn Trust, Dept Infect Dis, Liverpool, Merseyside, England
[4] Alder Hey Childrens NHS Fdn Trust, Dept Clin Biochem, Liverpool, Merseyside, England
[5] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Dept Haematol, Liverpool, Merseyside, England
[6] Univ Lancaster, Sch Hlth & Med, Lancaster, England
[7] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, NIHR Biomed Res Ctr, Liverpool, Merseyside, England
关键词
aPTT waveform; children; coagulation; meningococcal disease; sepsis; C-REACTIVE PROTEIN; CRITICALLY-ILL PATIENTS; LOW-DENSITY LIPOPROTEIN; EARLY IDENTIFICATION; PROGNOSTIC IMPLICATIONS; MARKER; MORTALITY; CHILDREN; DISEASE; COAGULATION;
D O I
10.1097/PCC.0b013e3182231034
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: A biphasic activated partial thromboplastin time waveform predicts sepsis and disseminated intravascular coagulation in adults. This has not been previously investigated in children. Our aim is to ascertain whether there are changes in the activated partial thromboplastin time waveform in children with meningococcal disease and to compare its diagnostic use with procalcitonin. Setting: Alder Hey Children's National Health Service Foundation Trust, Liverpool, UK. Patients: Thirty-six children admitted to the hospital for the treatment of suspected meningococcal disease had activated partial thromboplastin time waveform and procalcitonin analysis performed at admission. The light transmittance level at 18 secs was used to quantitate the waveform. Severity of disease was assessed using the Glasgow Meningococcal Septicaemia Prognostic Score, Pediatric Risk of Mortality III score, and the Pediatric Logistic Organ Dysfunction score. Measurements and Main Results: Twenty-four children had proven meningococcal disease, 12 had a presumed viral illness, and 20 control subjects were recruited. Transmittance level at 18 secs was lower in children with meningococcal disease and those with a viral illness (p < .0001) and control subjects (p < .0005). Sensitivity and specificity was 0.91 and 0.96 for transmittance level at 18 secs and 0.92 and 1 for procalcitonin in identifying meningococcal disease. There was a significant difference in procalcitonin between children with meningococcal disease and those with a viral illness and control subjects (p < .0005). A negative correlation was found between transmittance level at 18 secs and length of hospital stay (p < .0001), C-reactive protein (p < .0001), procalcitonin (p < .0001), Glasgow Meningococcal Septicaemia Prognostic Score (p < .01), Pediatric Risk of Mortality III score (p < .0001), and Pediatric Logistic Organ Dysfunction score score (p < .0001). Conclusion: The activated partial thromboplastin time waveform is abnormal in children with meningococcal disease and may be a useful adjunct in the diagnosis and management of sepsis in children. (Pediatr Crit Care Med 2011; 12:e322-e329)
引用
收藏
页码:E322 / E329
页数:8
相关论文
共 50 条
  • [41] Association of prothrombin time, thrombin time and activated partial thromboplastin time levels with preeclampsia: a systematic review and meta-analysis
    Alemayehu, Ermiyas
    Mohammed, Ousman
    Belete, Melaku Ashagrie
    Mulatie, Zewudu
    Debash, Habtu
    Gedefie, Alemu
    Weldehanna, Daniel Gebretsadik
    Eshetu, Bruktawit
    Shibabaw, Agumas
    Tekele, Saba Gebremichael
    Tilahun, Mihret
    Ebrahim, Hussen
    BMC PREGNANCY AND CHILDBIRTH, 2024, 24 (01)
  • [42] Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
    Wacker, Christina
    Prkno, Anna
    Brunkhorst, Frank M.
    Schlattmann, Peter
    LANCET INFECTIOUS DISEASES, 2013, 13 (05) : 426 - 435
  • [43] Prothrombin Time, Activated Partial Thromboplastin Time, Fibrinogen, and D-dimer as a Predictor of Decompensated Disseminated Intravascular Coagulation in Sepsis
    Fenny
    Dalimoenthe, Nadjwa Zamalek
    Noormartany
    Pranggono, Emmy
    Dewi, Nina Susana
    MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL, 2011, 43 (01): : 49 - 54
  • [44] The Effects of Plasma Prothrombine Time and Activated Partial Thromboplastin Time Based on Different Instruments and Methods
    Hernaningsih, Yetti
    Butarbutar, Trieva Verawaty
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (09) : EC21 - EC25
  • [45] Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population
    Zhang, Fan
    Mu, Guangyan
    Liu, Zhiyan
    Xie, Qiufen
    Zhang, Hanxu
    Zhou, Shuang
    Wang, Zhe
    Hu, Kun
    Wang, Zining
    Zhao, Xia
    Cui, Yimin
    Xiang, Qian
    GENES, 2022, 13 (10)
  • [46] Artifactual prolongation of the activated partial thromboplastin time by amikacin or gentamicin with ellagic acid, but not silica activated reagent
    Kaneko, Yousuke
    Sugasaki, Motoki
    Okada, Naoto
    Niimi, Mako
    Yasui, Saya
    Hori, Taiki
    Aihara, Ken-ichi
    Takishita, Makoto
    Abe, Masahiro
    Nakamura, Shingen
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (02) : E72 - E75
  • [47] Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients
    Atallah, S.
    Liebl, M.
    Fitousis, K.
    Bostan, F.
    Masud, F.
    PERFUSION-UK, 2014, 29 (05): : 456 - 461
  • [48] A gene-centric analysis of activated partial thromboplastin time and activated protein C resistance using the HumanCVD focused genotyping array
    Tom R Gaunt
    Gordon DO Lowe
    Debbie A Lawlor
    Juan-Pablo Casas
    Ian NM Day
    European Journal of Human Genetics, 2013, 21 : 779 - 783
  • [49] Evaluation of a bedside device to assess the activated partial thromboplastin time for heparin monitoring in infants
    Klein, Richard H.
    van der Vorst, Marja M. J.
    de Wilde, Rob B. P.
    Hogenbirk, Karin
    de Kam, Marieke L.
    Burggraaf, Jacobus
    BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (03) : 327 - 331
  • [50] What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time?
    Falay, Mesude
    Senes, Mehmet
    Yucel, Dogan
    Turhan, Turan
    Dagdas, Simten
    Pekin, Melike
    Nazaroglu, Namik K.
    Ozet, Gulsum
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (06)